PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0034069|lung fibrosis |
| Sentences | 1 |
| PubMedID- 23697753 | Assessment of the above panel of immunologic markers was performed at the following serial time points: 1) at time of diagnosis as a part of routine work-up in order to exclude collagen vascular diseases as a cause of lung fibrosis, and 2) at regular follow-up every 6 months or earlier than 6 months if clinical signs compatible with autoimmune disease (arthralgia, muscle weakness, dysphagia, raynaud’s phenomenon, photosensitivity) or disease exacerbation (dyspnea deterioration, hemoptysis, hematuria) emerged. |
Page: 1